Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 626 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07729176Enrolling by invitation
Flipped vs traditional teaching for surgical skills
This trial compares two ways of teaching basic surgical skills to first-year surgery trainees: traditional classroom teaching vs a flipped classroom approach where you watch videos before class and spend class time practicing. The goal is to find out which method helps you learn better.
Lahore, Punjab ProvinceAges Any age - NCT07662148RecruitingPhase 1
Testing the safety of BIIB144 in healthy adults
This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.
Las Vegas, NevadaAges 18–55 - NCT07363694RecruitingPhase 2/Phase 3
Study of PF-07275315 for moderate to severe COPD
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
Birmingham, AlabamaAges 35–80 - NCT06217107Recruiting
Wellness and work support for lupus and lupus nephritis
This study tests a wellness and work support program for women with lupus or lupus nephritis. The goal is to help you manage your health and connect with others through an online program.
Atlanta, GeorgiaAges 18 years+ - NCT06512454Recruiting
Study on inherited alpha-1 antitrypsin deficiency and related liver problems
This study looks at how alpha-1 antitrypsin deficiency affects the liver in adults. It aims to learn more about the liver problems caused by this condition and may help find better ways to manage them.
Gainesville, FloridaAges 18 years+ - NCT05189639Recruiting
Safety study of Mylotarg in newly diagnosed CD33-positive AML
This study follows people with newly diagnosed acute myeloid leukemia (AML) to check the safety of Mylotarg (also called gemtuzumab ozogamicin) as it’s used in routine care. It may help confirm how well the medicine is tolerated in real-world patients.
SeoulAges 19 years+ - NCT07723248RecruitingPhase 3
Oral Rinzimetostat for Advanced Prostate Cancer After Abiraterone
This study tests an experimental pill called rinzimetostat (ORIC-944) for men with advanced prostate cancer that has spread and stopped responding to abiraterone. It may offer a new option if you have not had many other treatments yet.
Charlotte, North CarolinaAges 18 years+ - NCT07721402RecruitingPhase 1
How prifetrastat is absorbed in healthy adults
This study tests how different forms of the study medicine prifetrastat enter the blood. It may help researchers understand the best way to give the medicine in future studies.
Brussels, Bruxelles-capitale, Région deAges 18 years+ - NCT07090499RecruitingPhase 1
Study of PF-08046876 for advanced solid tumors
This trial tests a new medicine, PF-08046876, for people with advanced cancers of the bladder, lung, head and neck, esophagus, or pancreas. It aims to see if the drug is safe and works against these cancers.
Duarte, CaliforniaAges 18 years+ - NCT07719387Enrolling by invitation
Vagus nerve stimulation to boost thinking and learning after stroke
This study tests if vagus nerve stimulation, delivered through an implanted device, can help improve thinking and learning in people who have had a stroke. You would use the device at home for six weeks.
Stony Brook, New YorkAges 22 years+ - NCT06853301Recruiting
A faster test to find bloodstream infections
This study tests a new machine learning method to quickly identify bacteria in the blood using special sample bottles. If you are getting blood cultures done already, this may help get results faster.
GrenobleAges 18 years+ - NCT07227298RecruitingPhase 1/Phase 2
Study of new drug combo for advanced lung cancer
This study tests a new combination of cancer drugs (PF-08634404 with other anticancer agents) for people with advanced non-small cell lung cancer who have not yet received any treatment for their advanced disease. It aims to see if this combination can shrink tumors or slow cancer growth.
Fayetteville, ArkansasAges 18 years+ - NCT07206225RecruitingPhase 1
Study of PF-08052667 in non-muscle invasive bladder cancer
This trial tests a new study medicine called PF-08052667 for people with a certain type of bladder cancer that hasn't spread into the muscle. It's for those who have already tried BCG treatment and can't or won't have their bladder removed.
Birmingham, AlabamaAges 18 years+ - NCT07318805RecruitingPhase 1
A study of PF-08032562 for advanced solid tumors
This study tests a new medicine, PF-08032562, for people with advanced breast or colorectal cancer that has not responded to prior treatments. It aims to see if the drug is safe and can help shrink or slow the cancer.
Duarte, CaliforniaAges 18 years+ - NCT06758401RecruitingPhase 3
Sigvotatug vedotin plus pembrolizumab for advanced lung cancer with high PD-L1
This trial tests a new combination of two study medicines for people with advanced non-small cell lung cancer that has high levels of PD-L1 protein. The goal is to see if adding sigvotatug vedotin to pembrolizumab works better than pembrolizumab alone.
Fullerton, CaliforniaAges 18 years+ - NCT03546387Recruiting
Anesthesia and brain thinking changes in children with retinoblastoma
This study looks at whether having anesthesia more than once (for eye/surgery treatment) affects children’s thinking and learning. It may help doctors plan safer care and better follow-up for children with retinoblastoma.
New York, New YorkAges 6–17 - NCT06649110RecruitingPhase 1/Phase 2
A study of LTP001 for healthy people and those with PAH
This study tests an investigational medicine called LTP001 for pulmonary arterial hypertension (PAH). Part A checks safety in healthy volunteers, and Part B tests if it helps people with PAH by improving blood flow in the lungs.
Scottsdale, ArizonaAges 18–100 - NCT07715617Recruiting
Creating a prediction score for lung transplant or death in Alpha-1 Antitrypsin Deficiency
This study is creating a simple scoring system to predict who with Alpha-1 Antitrypsin Deficiency-related emphysema might need a lung transplant or die from the disease. Your medical records from 2010–2025 will help build this tool, with no extra tests or visits required.
BronAges 18 years+ - NCT07714863Recruiting
Can machine learning predict ABPA recurrence?
This study uses a computer model to see if it can predict when ABPA (a lung condition) might come back. If you have ABPA and are stable after treatment, this could help doctors monitor you better.
Jinan, ShandongAges 18 years+ - NCT07620873Recruiting
Virtual Reality Education Before Kidney Stone Surgery
This study tests whether using virtual reality to learn about your upcoming kidney stone surgery can reduce anxiety and help you feel more prepared. You'll use a VR headset before your procedure to see what to expect.
KeelungAges 18 years+ - NCT03223090Recruiting
Motor language learning study for French speakers
This study tests how people learn language using brain-and-movement training (including tasks during brain scans and non-drug brain stimulation for some parts). It may help researchers understand learning and how the brain adapts during new language practice.
BronAges 20–40 - NCT03726047Recruiting
Exercise and training to improve walking after chronic stroke
This study tests whether exercise plus motor learning training can improve walking and movement after a stroke that happened more than 6 months ago. You may be a good candidate if you can walk on your own and your stroke-related brain injury is not mainly in the cerebellum.
Newark, DelawareAges 18–85 - NCT06808048Recruiting
Medical cannabis and behavior in chronic pain patients
This study looks at how medical cannabis affects thinking and behavior in people with chronic pain. It compares medical cannabis users to pain patients who don't use cannabis over a four-month period.
Minneapolis, MinnesotaAges 30–75 - NCT07702916Enrolling by invitation
Hygiene and menstruation study for girls in Madagascar
This trial looks at how hygiene and menstrual health programs affect learning and emotional well-being. If you are a girl in the Kilonga 2 study, you may be asked to complete surveys and some tests, and possibly provide saliva or blood samples.
AntananarivoAges 11–21
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 626 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.